Inoa | Tirzepatide i ka pauku |
ʻO Menu ka hoʻomaʻemaʻe | 99% |
Helehelena | Keʻokeʻo keʻokeʻo keʻokeʻo keʻokeʻo |
Papaho | Subcutaneous injection |
Nui | 10mg, 15mg, 20mg, 30mg |
Wai | 3.0% |
KA MANAWA | Ka mālamaʻana i ka maʻi diabetes, hoʻomaikaʻi i ke kahe koko koko |
ʻO Tirzepatide kahi mea maʻi Novel GLUCETROPIPIPOPIPOPY / GLUCAGON-ASSODER ADTERS ATTERS ATTERS ATTERS ACTERS ATTERS ACTERSE ATTERS ATTERS ACTERS ATCETES ʻO ka hoʻokele kaumahaʻana o ka modery Ua hoʻolālāʻia ka phase 3 1-5 no ka hoʻokolokolo hoʻokolokolo hoʻokolokolo e loiloi i ka hopena a me ka palekana o keʻano he nui. Hoʻohana i ka tirzepatide ma nā loiloi clinical i piliʻia e pili ana i nā ho'ēmiʻana o ka hemoglobin glycated (-1.9.2.2 Hoʻohuiʻia me nāʻano cardioterabolibolipomes cardiomethead e like me ke koko o ke koko,ʻike a me ke kauʻana i nā trigyriedides. Ua hana maikaʻiʻiaʻo Tirzepatide, me kahi haʻahaʻa haʻahaʻa o ka hypoglycaemia i ka wā i hoʻohanaʻia me kaʻole o ka palekana palekana Wahi a nā hōʻike hōʻike mai kēia mau hoʻokolohua lapaʻau e hōʻike ana i kēlā me ka nui o ka tirzepatide i kahi manawa hou no ka nui o ka hemoglobin a me ke kino o ke kino.